[
  {
    "ts": null,
    "headline": "UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade",
    "summary": "Viatris Inc. (NASDAQ:VTRS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. The third stock on our list of cheap pharmaceutical stocks is Viatris Inc. (NASDAQ:VTRS). TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11. The company’s stronger […]",
    "url": "https://finnhub.io/api/news?id=63c2091d23afd73c62d0ca681cd41269b8761ca2c23e9331092640daa5987dde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771404842,
      "headline": "UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade",
      "id": 139131632,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (NASDAQ:VTRS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. The third stock on our list of cheap pharmaceutical stocks is Viatris Inc. (NASDAQ:VTRS). TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11. The company’s stronger […]",
      "url": "https://finnhub.io/api/news?id=63c2091d23afd73c62d0ca681cd41269b8761ca2c23e9331092640daa5987dde"
    }
  }
]